Nancy A. Grygiel

SVP & CCO

Nancy A. Grygiel (SVP & CCO) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Amgen Inc. (AMGN). The largest single filing was $1.2M of AMGN (2,970 sh across 2 lots, as filed), executed Aug 6.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 3 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$2.7M

shares × price, as filed

Last traded

Aug 6

Filed Aug 7

Median ADV $1.1B across their filed names

Open performance→

Volume by month

Buys $0 Sells $3.5M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 3 filings

Sector per market data · by filing · past 12 months

Most traded names

AMGN

Amgen Inc. AMGN · 0 buys · 5 sells 5 filings

Recent filings

AMGNSALE Amgen Inc. View filing → $1.2M
2,970 sh across 2 lots
Exec Aug 6
Filed Aug 7 · 6:45 PM ET AMGNSALE Amgen Inc. View filing → $400K
1,237 sh × $323.73
Exec May 4
Filed May 5 · 5:30 PM ET AMGNSALE Amgen Inc. View filing → $1.1M
3,139 sh across 2 lots
Exec Nov 20 2025
Filed Nov 21 2025 · 5:30 PM ET AMGNSALE Amgen Inc. View filing → $376K
1,267 sh × $296.99
Exec Aug 20 2025
Filed Aug 22 2025 · 5:30 PM ET AMGNSALE Amgen Inc. View filing → $484K
1,589 sh × $304.47
Exec Feb 5 2025
Filed Feb 6 2025 · 5:30 PM ET